AME vs SLS · P/E 30, rev $2.04B vs $1.62B cap
Ametek Inc (AME) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported AME revenue for 2026-06-30 was $2.04B. Net income was $406.9M. Revenue was up 6.0% from 2026-03-31 to 2026-06-30. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.
AME currently screens at market cap $42.11B and trailing P/E 29.9. SLS currently screens at market cap $1.62B.
Not investment advice. Open the AME and SLS stock pages for the full models.
Not investment advice.